What Researchers Did
Researchers investigated whether perioperative hyperbaric oxygen therapy (HBOT) improved graft take in patients undergoing reoperative staged tubularized autograft repair for hypospadias using oral mucosa.
What They Found
Among 57 patients, 32 received HBOT and 25 did not. Patients receiving HBOT showed significantly less percent graft area contracture (9% vs 26%, p=0.04) and a lower rate of graft failure (6% vs 28%, p=0.03) compared to those not receiving therapy.
What This Means for Canadian Patients
For Canadian patients undergoing reoperations for failed hypospadias repairs, hyperbaric oxygen therapy could potentially improve surgical outcomes by promoting better graft healing. This may lead to fewer complications and a higher success rate for complex hypospadias repairs.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.
Study Limitations
A limitation is that treated patients had significantly more prior failed hypospadias repairs, and patients were not randomized to receive hyperbaric oxygen therapy.